Open AccessShould All Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease Receive an SGLT2 Inhibitor?
Author(s) -
Arden R. Barry,
Bradley R. Mitchelmore
Publication year - 2018
Publication title -
canadian journal of hospital pharmacy/the canadian journal of hospital pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.262
H-Index - 22
eISSN - 1920-2903
pISSN - 0008-4123
DOI - 10.4212/cjhp.v71i4.2831
Subject(s) - medicine , diabetes mellitus , type 2 diabetes mellitus , disease , type 2 diabetes , endocrinology
-